DIVISLAB

Divis Laboratories Ltd.

6,773.50+91.0 (+1.36%)
3 Jul, 9:59 AM

Annual Reports and Financial Documents

Divis Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Divis Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Closure of Trading Window30 Jun 2026
    Closure of Trading Window
    Intimation of closure of Trading Window from July 01, 2026.
  • General11 Jun 2026
    Information Regarding Deduction Of Income Tax At Source From Payment Of Dividend For The Financial Year 2025-26
    As per enclosed letter.
  • Newspaper Publication4 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copies of Newspaper Publication - Notice to the shareholders regarding transfer of unclaimed dividends and equity shares to IEPF
  • Newspaper Publication25 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publications regarding audited financial results of the Company for the quarter and year ended March 31, 2026
  • Analyst / Investor Meet23 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio recording of Q4 FY26 earnings conference call held on May 23, 2026.
  • Dividend Updates23 May 2026
    Announcement under Regulation 30 (LODR)-Dividend Updates
    The Board of Directors at its meeting held on May 23, 2026 have recommended a dividend of Rs. 30/- per share (i.e. @1500%), subject to approval at the ensuing Annual General Meeting.
  • Record Date23 May 2026
    Outcome Of Board Meeting - Dividend Recommended
    As per enclosed intimation letter.
  • Outcome of Board Meeting23 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On May 23, 2026
    Outcome of Board meeting held on May 23, 2026.
  • Analyst / Investor Meet15 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of schedule of earnings conference call for the quarter and year ended March 31, 2026 to be held on May 23, 2026 at 14:30 Hrs (IST).
  • Newspaper Publication15 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper Publication regarding loss of Share Certificate.
  • Board Meeting14 May 2026
    Board Meeting Intimation for Considering And Approving Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2026 And To Recommend Dividend, If Any, For The Financial Year 2025-26.
    Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve audited standalone and consolidated ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate pursuant to Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.
  • Closure of Trading Window31 Mar 2026
    Closure of Trading Window
    Intimation of closure of Trading Window from April 01, 2026 till 48 hours of declaration of audited financial results for the quarter and financial year ended March 31, 2026.
  • General21 Mar 2026
    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
    Intimation about Draft Order issued under Section 144C(1) of the Income Tax Act, 1961 for FY2022-23.
  • Newspaper Publication14 Mar 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper clippings - Special Window for transfer and dematerialisation of physical shares.
  • Newspaper Publication12 Feb 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As enclosed
  • Analyst / Investor Meet11 Feb 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio recording of Q3FY26 earnings conference call held on February 11, 2026.
  • Outcome of Board Meeting11 Feb 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On February 11, 2026
    Outcome of Board Meeting held on February 11, 2026.
  • Analyst / Investor Meet3 Feb 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Schedule of earnings conference call for Q3FY26 to be held on February 11, 2026 at 15.00 hrs (IST).
  • Board Meeting30 Jan 2026
    Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025.
    Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve the unaudited financial ....

Frequently Asked Questions

Where can I download the annual report of Divis Laboratories Ltd.?
Annual reports of Divis Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Divis Laboratories Ltd.?
Quarterly earnings results and presentations of Divis Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Divis Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Divis Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Divis Laboratories Ltd.?
Investor presentations and annual day presentations of Divis Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Divis Laboratories Ltd.?
Corporate announcements and regulatory filings of Divis Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Divis Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Divis Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Divis Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Divis Laboratories Ltd. is INE361B01024. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Divis Laboratories Ltd. listed?
Divis Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is DIVISLAB and the BSE code is -.
Where can I find the shareholding pattern of Divis Laboratories Ltd.?
The quarterly shareholding pattern of Divis Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Divis Laboratories Ltd. on Sharpely?
Share price data for Divis Laboratories Ltd. is updated as of 3 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.